FDA Approved: NITROSTAT — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

The FDA approved a supplemental application for Nitrostat (nitroglycerin) submitted by Viatris Specialty LLC, resulting in an updated labeling for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• Nitrostat (Nitroglycerin)

Snippet

SUPPL AP for NITROSTAT (NITROGLYCERIN)